Skip to content
Search

Latest Stories

Most pharmacists agree focusing on 'preventive care' is crucial

Most pharmacists agree focusing on 'preventive care' is crucial

Funding and collaboration challenges hindering pharmacists' efforts to address global health needs

In preparation for World Pharmacists Day on September 25, Pharmacy Business conducted a social media poll to explore how pharmacists can improve global health outcomes.

More than 64 per cent of respondents indicated that pharmacists should prioritize promoting preventive care.


Other suggestions included advancing research and development (9 per cent), increasing interdisciplinary collaboration (14 per cent), and addressing health disparities (14 per cent).

This year's theme for World Pharmacists Day is “Pharmacists: Meeting Global Health Needs.”

The International Pharmaceutical Federation (FIP) emphasises that pharmacists are integral members of healthcare systems, playing a crucial role in meeting health needs in various ways daily.

Key contributions from pharmacists include:

  • Ensuring access to essential medicines and their optimal use, which significantly enhances patient care and public health.
  • Serving as the first point of contact for health advice and primary healthcare, particularly in resource-limited settings.
  • Helping prevent diseases by administering vaccinations, conducting health screenings, educating patients, and improving health literacy.
  • Supporting public health campaigns, participating in research and development of new medicines, leading pharmacovigilance efforts, and ensuring judicious use of antibiotics.
  • Implementing more sustainable practices and addressing the health impacts of climate change.
  • Advocating for policy changes that promote better health outcomes.
  • Demonstrating their vital role in tackling global health crises, as seen during the COVID-19 pandemic.

Pharmacists could make a greater impact on global health if they are provided sufficient funding.

Over 90 per cent of respondents identified inadequate funding as the primary challenge pharmacists encounter in addressing global health needs, while 9 per cent pointed to limited access to technology.

The National Pharmacy Association (NPA) has been calling on the government to reverse the 40 per cent real-terms cuts to community pharmacy budgets over the past decade, which have led to the closure of over 1,500 pharmacies and forced many others to reduce their opening hours.

It cautioned that many rural areas could become 'pharmacy deserts' if the current closure rates persist.

In the Pharmacy Business online poll, only four per cent of respondents expressed satisfaction with the level of support community pharmacies receive from the government, while 31per cent indicated they were "dissatisfied," and 65per cent reported being "very dissatisfied."

Furthermore, more than 70 per cent of participants believe the current level of collaboration between community pharmacies and other healthcare professionals is ineffective.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less